Outperform Recommendation Issued On CNTB By Oppenheimer

July 09, 2026 09:15:11 am

Source: KlickAnalytics

2026-07-09 09:15:11 ET

Oppenheimer analyst issues OUTPERFORM recommendation for CNTB on July 9, 2026 11:57AM ET.

CNTB was trading at $2.22 at issue of the analyst recommendation.

The overall analyst consensus : BUY.

Current analyst recommendations are : 5 - Buy recommendations .

Latest 10 recommendations

Report Date

Connect Biopharma Holdings Limited

NASDAQ: CNTB

CNTB Trading

-11.26% G/L:

$2.245 Last:

368,196 Volume:

$2.49 Open:

CNTB Latest News

July 09, 2026 09:15:11 am

June 26, 2026 07:15:06 am

June 17, 2026 09:00:00 am

May 12, 2026 04:05:00 pm

Market Cap $149,262,380

Float 15,429,370

Insiders Ownership N/A

Institutions 7

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Country CN

City San Diego